Mechanism of action of Type 2 Sodium-Glucose Cotransporter Inhibitors: Beyond glycaemic control: Más allá del control de la glicemia

Keyphrases

• Mechanism of Action 100%
• Glycemic Control 100%
• Sodium-glucose Cotransporter Inhibitors 100%
• Cardiovascular Effects 100%
• Metabolism 50%
• Myocardial Cells 50%
• Kidney 50%
• Hematocrit 50%
• Adipose Tissue 50%
• Novel Mechanism 50%
• Hypotensive Effect 50%
• Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i) 50%
• Glucose Reabsorption 50%
• Renal Effects 50%
• Cardiac Failure 50%
• Sodium-glucose Cotransporter 50%
• Uric Acid 50%
• Nonglycemic Effect 50%
• Glucose-lowering Drugs 50%
• Urinary Albumin 50%

Medicine and Dentistry

• Cardiovascular System 100%
• Sodium Glucose Cotransporter 2 Inhibitor 100%
• Glycemic Control 100%
• Congestive Heart Failure 50%
• Adipose Tissue 50%
• Hematocrit 50%
• Glycemic 50%
• Uric Acid 50%
• Sodium Glucose Cotransporter 2 50%
• Albumin 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Congestive Heart Failure 100%
• Sodium Glucose Cotransporter 2 100%
• sodium glucose cotransporter-2 inhibitors 100%
• Albumin 100%
• Sodium Glucose Cotransporter 2 Inhibitor 100%
• Uric Acid 100%